title: [Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].
abstract: BACKGROUND
  Red cell Cartwright antigen (Yta) is very common in the general population therefore patients without red cell Cartwright antigen and with anti-Yta alloantibodies due to previous exposure to the antigen are rare. Report about clinical significance of Yta red cell alloantibodies in hemodialysis (HD) patients are scarce.
  
  
  METHODS
  We report a cirrhotic uremic patient with anti-Yta antibodies who received Yta positive red cells. No adverse reactions nor hemolysis were detected.
  
  
  CONCLUSIONS
  We concluded that dialysis patients with anti-Yta antibodies could be safely transfused with blood from Cartwright positive donors.
authors.affiliation: Servizio di Immunoematologia e Trasfusione, Ospedale Civile Maggiore, Verona.
authors.forename: M
authors.initials: M
authors.lastname: Franchini
authors.forename: F
authors.initials: F
authors.lastname: Fabbian
authors.forename: P L
authors.initials: PL
authors.lastname: Piccoli
authors.forename: G
authors.initials: G
authors.lastname: Gandini
authors.forename: G
authors.initials: G
authors.lastname: Aprili
authors.forename: C
authors.initials: C
authors.lastname: Loschiavo
authors.forename: A
authors.initials: A
authors.lastname: Lupo
mesh_terms: D000328:Adult; D001803:Blood Transfusion; D004912:Erythrocytes / Q000276:immunology*; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D007519:Isoantigens / Q000276:immunology*; D008297:Male; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood* / Q000628:therapy*
chemical_list: D007518:Isoantibodies; D007519:Isoantigens